Eyecare Republic (ECR) announced a strategic partnership with Avulux, a company specializing in Migraine & Light Sensitivity Lenses.
Avulux lenses utilize patented precision technology to filter up to 97% of the harmful light wavelengths that trigger migraine attacks—a critical innovation given that light triggers over 60% of migraine episodes. The lenses are the only migraine and light sensitivity lenses with clinical validation.
“We’re proud to partner with Eyecare Republic to bring this meaningful product into everyday patient care,” said Derek Johnson, Director of Strategic Accounts at Avulux. “By combining Avulux’s patented light-filtering technology with Eyecare Republic’s patient-first approach, we’re creating new opportunities to support eye care professionals. Together, we can help practices deliver migraine solutions, confidence and better quality of life for patients living with light sensitivity and migraine.”
Dr. Justin Weigel, a founding optometrist of Eyecare Republic, emphasized the clinical value of the collaboration: “Migraine management requires a comprehensive approach. By partnering with Avulux, we’re addressing one of the most undertreated aspects of migraine care—light sensitivity. This reflects our commitment to providing complete, patient-centered solutions.”
